LWAC

Locust Walk Acquisition Corp.

Price

$10.33

return (12m)

p/e

29.99

p/bv

-30.66

DIVIDEND YIELD

0.00%

LWAC price

Locust Walk Acquisition

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment LWAC

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-0.19%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals LWAC

Valuation

P/E

29.99

Sector -3.50

Industry -3.50

P/BV

-30.66

Sector 2.02

Industry 2.02

P/Revenue (PSR)

Sector 2.01

Industry 2.01

EV/EBITDA

-653.73

Sector -214.99

Industry -214.99

EV/EBIT

-653.73

Sector -47.59

Industry -47.59

P/EBITDA

-328.04

Sector -21.41

Industry -21.41

P/EBIT

-328.04

Sector -28.65

Industry -28.65

P/Total Assets

0.99

Sector 1.19

Industry 1.19

P/Net Current Assets

-30.66

Sector -11.97

Industry -11.97

P/Working Capital

787.07

Sector -167.95

Industry -167.95

EPS

0.34

Sector -1.81

Industry -1.81

BVPS

-0.34

Sector 2.06

Industry 2.06

Efficiency

Gross Margin

0.00%

Sector 41.30%

Industry 41.30%

EBITDA Margin

Sector -17,117.21%

Industry -17,117.21%

EBIT Margin

Sector -4,185,659.35%

Industry -4,185,659.35%

Operating Margin

0.00%

Sector -35.21%

Industry -35.21%

Net Profit Margins

0.00%

Sector -35.91%

Industry -35.91%

Asset Turnover

0.00

Sector 0.02

Industry 0.02

Profitability

ROE

-102.24%

Sector -56.04%

Industry -56.04%

ROA

3.31%

Sector -60.31%

Industry -60.31%

ROIC

-0.61%

Sector -2,335.95%

Industry -2,335.95%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

0.00%

Sector -

Industry -

Debt

Current Ratio

1.83

Sector 2.89

Industry 2.89

Net Debt / EBITDA

1.39

Sector -14,066,680.10

Industry -14,066,680.10

Net Debt / EBIT

1.39

Sector -8.06

Industry -8.06

Net Debt / Equity

0.07

Sector -33,024.69

Industry -33,024.69

Gross Debt / Equity

0.00

Sector -0.85

Industry -0.85

Equity/Assets

-0.03

Sector 0.46

Industry 0.46

Liabilities/Assets

0.04

Sector 0.41

Industry 0.41

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

Fundamentals LWAC

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
LWAC Locust Walk Acquisition Corp.	$10.33	-	0.00%	29.99	-30.66	-102.24%	0.00%
JNJ Johnson & Johnson	$269.33	55.44%	1.96%	30.82	7.63	24.76%	21.48%
PFE Pfizer Inc.	$27.49	22.33%	6.26%	35.85	1.83	5.11%	6.86%
ABBV AbbVie Inc.	$263.93	23.34%	2.59%	73.99	-78.76	-106.44%	9.81%
NVO Novo Nordisk A/S	$43.19	-26.70%	4.29%	10.56	5.61	53.11%	35.32%
MRK Merck & Co. Inc.	$146.11	87.14%	2.31%	113.21	8.55	7.55%	4.76%
AZN AstraZeneca PLC	$166.35	9.78%	1.94%	19.88	5.12	25.77%	16.95%
BMY Bristol-Myers Squibb Company	$62.71	43.77%	4.04%	13.67	5.68	41.55%	18.85%
ZTS Zoetis Inc.	$72.66	-49.60%	2.88%	11.47	9.64	84.02%	27.77%
AMGN Amgen Inc.	$383.04	43.28%	2.60%	23.66	17.70	74.80%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$784.44	31.54%	0.47%	18.63	2.54	13.65%	27.86%
HALO Halozyme Therapeutics Inc.	$111.35	46.87%	0.00%	31.57	90.97	288.13%	24.86%
MCK McKesson Corporation	$874.67	27.00%	0.38%	19.57	-26.84	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$506.08	30.72%	0.00%	29.15	6.34	21.76%	35.00%
CAH Cardinal Health Inc.	$224.45	52.89%	0.91%	30.53	-19.32	-63.29%	0.68%
ARGX argenx SE	$994.44	35.42%	0.00%	2.24	2.63	117.11%	44.68%
HRMY Harmony Biosciences Holdings Inc.	$42.23	31.71%	0.00%	13.50	2.45	18.14%	18.88%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

LWAC Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Locust Walk Acquisition

Locust Walk Acquisition Corp.

Average Investor10 user rating

4.0 (0 people)

United States

- year

Founded:

2025

Time since IPO - 1 year

-

Employees

Locust Walk Acquisition Corp. (United States) is listed on the Nasdaq and has a market capitalization of $222.74 million, with shareholders equity totaling $-7.26 million.

The Company is listed on the [MARKET_NAME]

Over the past 12 months, Locust Walk Acquisition Corp. reported $- in revenue, generating net income of $7.43 million.

Key financial metrics include a P/E ratio of 29.99, a price-to-book (P/B) ratio of -30.66, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker LWAC.

Market cap

$222.74 million

Net worth

$-7.26 million

$-7,264,000.00

Assets

$224.60 million

$224,602,000.00

Total Shares Outstanding

21.56 million

21,562,000

Average Daily Trading Volume

$24.16 Thousand

$24,164.84

Sector

Health Care

Industry

Biotechnology

LWAC

LWAC revenue and profits

Financial Results LWAC

DRAG THE FRAME TO SEE MORE DATA

LWAC cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$874.67 25,76% (12M)

P/E

19.57

0.38%

ROE

-137.16%

P/BV

-26.84

CAH - Cardinal Health

$224.45 51,61% (12M)

P/E

30.53

0.91%

ROE

-63.29%

P/BV

-19.32

JNJ - Johnson & Johnson

$269.33 56,33% (12M)

P/E

30.82

1.96%

ROE

24.76%

P/BV

7.63

ABBV - AbbVie

$263.93 22,42% (12M)

P/E

73.99

2.59%

ROE

-106.44%

P/BV

-78.76

MRK - Merck & Co.

$146.11 85,19% (12M)

P/E

113.21

2.31%

ROE

7.55%

P/BV

8.55

AZN - AstraZeneca

$166.35 9,17% (12M)

P/E

19.88

1.94%

ROE

25.77%

P/BV

5.12

PFE - Pfizer

$27.49 22,43% (12M)

P/E

35.85

6.26%

ROE

5.11%

P/BV

1.83

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$874.67 25,76% (12 M)

P/L

19.57

0.38%

ROE

-137.16%

P/VP

-26.84

CAH - Cardinal Health

$224.45 51,61% (12 M)

P/L

30.53

0.91%

ROE

-63.29%

P/VP

-19.32

JNJ - Johnson & Johnson

$269.33 56,33% (12 M)

P/L

30.82

1.96%

ROE

24.76%

P/VP

7.63

ABBV - AbbVie

$263.93 22,42% (12 M)

P/L

73.99

2.59%

ROE

-106.44%

P/VP

-78.76

MRK - Merck & Co.

$146.11 85,19% (12 M)

P/L

113.21

2.31%

ROE

7.55%

P/VP

8.55

AZN - AstraZeneca

$166.35 9,17% (12 M)

P/L

19.88

1.94%

ROE

25.77%

P/VP

5.12

PFE - Pfizer

$27.49 22,43% (12 M)

P/L

35.85

6.26%

ROE

5.11%

P/VP

1.83

Frequently Asked Questions

What is the price of Locust Walk Acquisition (LWAC) today?

A cotação de Locust Walk Acquisition (LWAC) hoje está em US$ 10.33, com uma variação de 0% em relação ao último ano. A cotação de Locust Walk Acquisition (LWAC) iniciou o ano negociando na casa dos US$ 0.00 e hoje está em US$ 10.33. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Locust Walk Acquisition (LWAC) e dados de ações do Ibovespa e mercados internacionais.

Quando Locust Walk Acquisition (LWAC) paga dividendos?

Locust Walk Acquisition (LWAC) não distribuiu dividendos no último ano.

Is Locust Walk Acquisition (LWAC) a good investment?

Atualmente, Locust Walk Acquisition (LWAC) está cotada a US$ 10.33, com um P/L de 29.99, representando um desvio de 1,500% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 0 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 0.00%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Locust Walk Acquisition (LWAC) stock?

Investir em ações de Locust Walk Acquisition (LWAC) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Locust Walk Acquisition (LWAC) yield today?

A rentabilidade de Locust Walk Acquisition (LWAC) foi de -0.19% no último mês, 0.00% no último ano e 0.00% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Locust Walk Acquisition (LWAC) hoje, o investimento total seria de US$ 1,033.00, com base na cotação atual de US$ 10.33.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 1,033.00
Em 5 anos: US$ 1,033.00
Em 10 anos: US$ 1,033.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

LWAC

Locust Walk Acquisition Corp.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment LWAC

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING LWAC WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Locust Walk Acquisition

Locust Walk Acquisition Corp.

United States

- year

2025

-

Financial Results LWAC

LWAC cash flow

Asset, Revenue and Profit Growth - LWAC

LWAC balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions